STADA Arzneimittel AG
03.07.2014 13:04
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
On July 01, 2014, LSV Asset Management, Wilmington, Delaware, USA has
informed us according to Article 21, Section 1 of the WpHG that via shares
its Voting Rights on STADA Arzneimittel AG, Bad Vilbel, Deutschland, have
exceeded the 3% threshold of the Voting Rights on June 23, 2014 and on that
day amounted to 3.07% (this corresponds to 1856353 Voting Rights).
0.36% of Voting Rights (this corresponds to 219100 Voting Rights) are
attributed to the company in accordance with Article 22, Section 1,
Sentence 1, No. 1 of the WpHG (German Securities Trading Act).
2.71% of Voting Rights (this corresponds to 1637253 Voting Rights) are
attributed to the company in accordance with Article 22, Section 1,
Sentence 1, No. 6 of the WpHG (German Securities Trading Act).
03.07.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AG
StadastraÃe 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-PVR: STADA Arzneimittel AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution - Correction of Announcement of 26.6.2014
| Source: EQS Group AG